• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如果患者提出要求,而没有证据表明其有益,那么提供 IVF 附加服务是否符合伦理?

Is it ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it?

机构信息

Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.

出版信息

J Med Ethics. 2019 May;45(5):346-350. doi: 10.1136/medethics-2018-104983. Epub 2019 Feb 11.

DOI:10.1136/medethics-2018-104983
PMID:30745435
Abstract

In vitro fertilisation (IVF) 'add-ons' are therapeutic or diagnostic tools developed in an endeavour to improve the success rate of infertility treatment. However, there is no conclusive evidence that these interventions are a beneficial or effective adjunct of assisted reproductive technologies. Additionally, IVF add-ons are often implemented in clinical practice before their safety can be thoroughly ascertained. Yet, patients continue to request and pay large sums for such additional IVF tools. Hence, this essay set out to examine if it is ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it. In order to determine what is ethical-namely, morally good and righteous, the question was considered in relation to three key values of medical ethics-autonomy, beneficence and non-maleficence. It was determined that providing IVF add-ons might be morally acceptable in specific circumstances, if true informed consent can be given, there is a potential of cost-effective physiological or psychological benefit and the risk of harm is minimal, particularly with regard to the unborn child.

摘要

体外受精(IVF)“附加物”是为了提高不孕治疗成功率而开发的治疗或诊断工具。然而,没有确凿的证据表明这些干预措施是辅助生殖技术的有益或有效辅助手段。此外,IVF 附加物通常在其安全性得到充分确定之前就在临床实践中实施。然而,患者仍然要求并支付大量费用来获得这些额外的 IVF 工具。因此,本文旨在探讨在没有证据表明患者有获益的情况下,是否可以提供 IVF 附加物。为了确定什么是合乎道德的——即道德上的善和正义,这个问题是根据医学伦理学的三个关键价值观来考虑的——自主性、善行和不伤害。如果能够给予真正的知情同意,如果有潜在的经济有效的生理或心理获益,并且风险很小,特别是对未出生的孩子,那么在特定情况下提供 IVF 附加物可能在道德上是可以接受的。

相似文献

1
Is it ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it?如果患者提出要求,而没有证据表明其有益,那么提供 IVF 附加服务是否符合伦理?
J Med Ethics. 2019 May;45(5):346-350. doi: 10.1136/medethics-2018-104983. Epub 2019 Feb 11.
2
Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons.点菜式菜单是否适合不孕患者?体外生育附加条件的伦理与监管。
Fertil Steril. 2019 Dec;112(6):973-977. doi: 10.1016/j.fertnstert.2019.09.028. Epub 2019 Nov 5.
3
In vitro fertilization add-ons for the endometrium: it doesn't add-up.体外受精对子宫内膜的附加作用:这并不成立。
Fertil Steril. 2019 Dec;112(6):987-993. doi: 10.1016/j.fertnstert.2019.10.011.
4
Building an evidence base for IVF 'add-ons'.建立体外受精“附加疗法”的证据基础。
Reprod Biomed Online. 2019 Jun;38(6):853-856. doi: 10.1016/j.rbmo.2019.04.005. Epub 2019 Apr 10.
5
The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites.生育诊所网站上三种试管婴儿附加服务的流行程度、推广情况和定价。
Reprod Biomed Online. 2020 Nov;41(5):801-806. doi: 10.1016/j.rbmo.2020.07.021. Epub 2020 Jul 27.
6
Ethics and IVF add-ons: We need to talk about it.伦理与 IVF 附加条件:我们需要对此进行讨论。
JBRA Assist Reprod. 2022 Aug 4;26(3):371-373. doi: 10.5935/1518-0557.20220030.
7
Moral justification for the use of 'add-ons' in assisted reproductive technology: experts' views and experiences.辅助生殖技术中使用“附加技术”的伦理依据:专家观点与经验
Reprod Biomed Online. 2024 Feb;48(2):103637. doi: 10.1016/j.rbmo.2023.103637. Epub 2023 Oct 22.
8
Clinical adjuncts in in vitro fertilization: a growing list.体外受精中的临床辅助手段:日益增多。
Fertil Steril. 2019 Dec;112(6):978-986. doi: 10.1016/j.fertnstert.2019.09.019. Epub 2019 Nov 5.
9
Add-ons in the laboratory: hopeful, but not always helpful.实验室中的附加物:有希望,但并不总是有帮助。
Fertil Steril. 2019 Dec;112(6):994-999. doi: 10.1016/j.fertnstert.2019.10.031.
10
The efficacy of add-ons: selected IVF "add-on" procedures and future directions.附加治疗的疗效:精选的 IVF“附加”程序和未来方向。
J Assist Reprod Genet. 2022 Mar;39(3):581-589. doi: 10.1007/s10815-022-02410-6. Epub 2022 Jan 23.

引用本文的文献

1
Commercial Impacts on Assisted Reproductive Technology: A Scoping Review.商业对辅助生殖技术的影响:一项范围综述
J Bioeth Inq. 2025 Sep 11. doi: 10.1007/s11673-025-10456-1.
2
Private equity and reproductive medicine: "Fertile breeding ground" - a physician's perspective".私募股权与生殖医学:“肥沃的滋生地”——一位医生的视角
Reprod Biol Endocrinol. 2025 Aug 1;23(1):113. doi: 10.1186/s12958-025-01446-4.
3
Do Doctors Have a Responsibility to Challenge the Distorting Influence of Commerce on Healthcare Delivery? The Case of Assisted Reproductive Technology.
医生有责任挑战商业对医疗服务的扭曲影响吗?以辅助生殖技术为例。
Health Care Anal. 2025 Mar;33(1):63-75. doi: 10.1007/s10728-024-00500-3. Epub 2024 Nov 19.
4
[Some present and future ethical dilemmas surrounding advancements in in vitro fertilization.].[围绕体外受精技术进步的一些当前和未来的伦理困境。]
Salud Colect. 2023 Nov 16;19:e4462. doi: 10.18294/sc.2023.4462.
5
Hope and Exploitation in Commercial Provision of Assisted Reproductive Technologies.商业化提供辅助生殖技术中的希望与剥削。
Hastings Cent Rep. 2023 Sep;53(5):30-41. doi: 10.1002/hast.1513.
6
Ethics and IVF add-ons: We need to talk about it.伦理与 IVF 附加条件:我们需要对此进行讨论。
JBRA Assist Reprod. 2022 Aug 4;26(3):371-373. doi: 10.5935/1518-0557.20220030.
7
Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses.优化接受辅助受孕的女性胚胎移植的干预措施:全面系统评价和荟萃分析。
Hum Reprod Update. 2022 Jun 30;28(4):480-500. doi: 10.1093/humupd/dmac009.
8
Revisiting selected ethical aspects of current clinical in vitro fertilization (IVF) practice.重新审视当前临床体外受精 (IVF) 实践中的部分伦理问题。
J Assist Reprod Genet. 2022 Mar;39(3):591-604. doi: 10.1007/s10815-022-02439-7. Epub 2022 Feb 22.
9
Polygenic risk scoring of human embryos: a qualitative study of media coverage.多基因风险评分在人类胚胎中的应用:媒体报道的定性研究。
BMC Med Ethics. 2021 Sep 18;22(1):125. doi: 10.1186/s12910-021-00694-4.
10
VALUE study: a protocol for a qualitative semi-structured interview study of IVF add-ons use by patients, clinicians and embryologists in the UK and Australia.VALUE 研究:一项在英国和澳大利亚对 IVF 附加治疗的使用进行定性半结构式访谈研究的方案,研究对象包括患者、临床医生和胚胎学家。
BMJ Open. 2021 May 21;11(5):e047307. doi: 10.1136/bmjopen-2020-047307.